InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 03/28/2019 4:04:32 PM

Thursday, March 28, 2019 4:04:32 PM

Post# of 651
News: $BVXV BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at IVW2019 Conference

JERUSALEM , March 28, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), developer of the M-001 universal influenza vaccine candidate, reported today it will present next week at the Influenza Vaccines for the World conference in Edinburgh, Scotland , UK. ...

Got this from https://marketwirenews.com/news-releases/biondvax-to-provide-update-of-m-001-universal-flu-vaccine-pivotal-phase-3-clinical-trial-at-ivw2019-conference-7905390.html